0.1872SEK-3.31%Mkt Cap: 127.27M SEKP/E: —Last update: 2026-05-13
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antib…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)0.03
PEG—
P/B1.97
P/S185.79
EV/EBITDA-0.76
EV/Revenue89.48
EPS (TTM)-0.26
EPS (Forward)7.00
Cash Flow & Leverage
FCF Yield-34.48%
FCF Margin-6406.53%
Operating CF-78.40M SEK
CapEx (TTM)5.56M SEK
Net Debt/EBITDA0.95
Net Debt-76.60M SEK
Technical
SMA 500.1893 (-1.1%)
SMA 2000.2832 (-33.9%)
Beta2.66
S&P 52W Chg24.23%
Avg Vol (30d)7.18M
Avg Vol (10d)9.16M
Technical Indicators
RSI (14)45.2
MACD-0.0009
MACD Signal0.0019
MACD Hist.-0.0028
BB Upper0.2346 SEK
BB Middle0.2053 SEK
BB Lower0.1759 SEK
BB Width28.59%
ATR (14)0.0210 SEK
Vol Ratio (20d)0.20x
52W Range
0.15026% of range0.7527
52W High0.7527 SEK
52W Low0.1502 SEK
Profitability
Gross Margin80.15%
EBITDA Margin0.00%
Profit Margin-21301.46%
Oper. Margin-4626.27%
ROE-225.30%
ROA-165.41%
Revenue Growth-22.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.01
Current Ratio5.12
Quick Ratio5.02
Book Value/Sh0.0960 SEK
Cash/Share0.1150 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateFeb 3, 2026
Ownership
Shares Out.672.67M
Float607.39M
Insiders18.68%
Institutions7.57%
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)0.4200 SEK
Target Range0.4200 SEK – 0.4200 SEK
# Analysts1
Company
Market Cap127.27M SEK
Enterprise Value61.29M SEK
Revenue (TTM)685.00K SEK
Gross Profit549.00K SEK
Net Income (TTM)-145.91M SEK
Revenue/Share0.0020 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees13
Last Price0.1872 SEK
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISINSE0006091997